TapewireFind a company

person · Reporting owner

Cassidy Sean A

Disclosed activity across 2 companies

Tapewire entity
88796
SEC CIK
0001421914

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
ARVINAS, INC.ARVN · Entity 5355Chief Financial OfficerFebruary 23, 2024February 27, 2024
HOOKIPA Pharma Inc.HOOK · Entity 15295DirectorJuly 22, 2024July 24, 2024

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ARVINAS, INC.

Report date February 23, 2024 · Filed February 27, 2024

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect181,916 Reported balance After 2024-02-23 transaction · row 1
1 source row

Row 1 · 2024-02-23 · Sale · Disposed 1,702 · Balance 181,916

F1: This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units.

Filing footnotes · ownership attribution and instrument terms

F1: This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units.

HOOKIPA Pharma Inc.

Report date July 22, 2024 · Filed July 24, 2024

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.44 · Expires 2034-07-22Direct9,800 Reported balance After 2024-07-22 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2024-07-22 · Grant · Acquired 9,800 · Balance 9,800

F1: The shares subject to this option will vest in thirty-six equal monthly installments commencing July 22, 2024, subject to Reporting Person's continuous service through each such date.

Filing footnotes · ownership attribution and instrument terms

F1: The shares subject to this option will vest in thirty-six equal monthly installments commencing July 22, 2024, subject to Reporting Person's continuous service through each such date.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
March 23, 2020 Filed Mar 24, 2020 07:30 UTC ARVINAS, INC. ARVN · Entity 5355 Exercise / conversionCommon Stock 8,030 $16.00 $128,480.00
Disclosure

SEC source: 0001209191-20-020803 · doc4.xml · nonDerivative · entry 1

Cassidy Sean A · CIK 0001421914 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,422

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 19, 2020 Filed Mar 23, 2020 21:35 UTC ARVINAS, INC. ARVN · Entity 5355 Exercise / conversionRestricted Stock Units · Derivative 4,791 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-020795 · doc4.xml · derivative · entry 3

Cassidy Sean A · CIK 0001421914 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,374

Underlying: Common Stock · 4,791 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock.

F4 · derivative.exercise_date: On March 1, 2019, the reporting person was granted 19,165 Restricted Stock Units, vesting in four equal annual installments beginning March 1, 2020.

F4 · derivative.expiration_date: On March 1, 2019, the reporting person was granted 19,165 Restricted Stock Units, vesting in four equal annual installments beginning March 1, 2020.

Read SEC document
March 19, 2020 Filed Mar 23, 2020 21:35 UTC ARVINAS, INC. ARVN · Entity 5355 SaleCommon Stock 1,514 $37.61 $56,941.54
Disclosure

SEC source: 0001209191-20-020795 · doc4.xml · nonDerivative · entry 2

Cassidy Sean A · CIK 0001421914 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,392

F2 · shares: This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units.

F3 · price: The broker sold shares of Arvinas Common Stock for certain Arvinas employees following the vesting of previously granted Restricted Stock Units, including the Common Stock reported on this Form 4 by the Reporting Person, at an average price of $37.61.

Read SEC document
March 19, 2020 Filed Mar 23, 2020 21:35 UTC ARVINAS, INC. ARVN · Entity 5355 Exercise / conversionCommon Stock 4,791 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-020795 · doc4.xml · nonDerivative · entry 1

Cassidy Sean A · CIK 0001421914 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 153,906

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
February 27, 2020 Filed Mar 2, 2020 17:29 UTC ARVINAS, INC. ARVN · Entity 5355 GrantStock Option (right to buy) · Derivative 75,000 $0.00 Strike: $47.38 $0.00
Disclosure

SEC source: 0001209191-20-014640 · doc4.xml · derivative · entry 1

Cassidy Sean A · CIK 0001421914 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2030-02-26

F1 · derivative.exercise_date: This option award was granted on February 27, 2020. 1/4 of the shares underlying the award shall vest on February 27, 2021, with the remainder of the shares vesting in equal monthly installments following February 27, 2021 through February 27, 2024.

Read SEC document
February 07, 2020 Filed Feb 11, 2020 18:00 UTC ARVINAS, INC. ARVN · Entity 5355 SaleCommon Stock 30 $54.10 $1,623.00
Disclosure

SEC source: 0001209191-20-008425 · doc4.xml · nonDerivative · entry 5

Cassidy Sean A · CIK 0001421914 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 149,115

F1 · kind: The sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by the reporting person on December 20, 2019.

Read SEC document
February 07, 2020 Filed Feb 11, 2020 18:00 UTC ARVINAS, INC. ARVN · Entity 5355 SaleCommon Stock 1,302 $52.86 $68,823.72
Disclosure

SEC source: 0001209191-20-008425 · doc4.xml · nonDerivative · entry 4

Cassidy Sean A · CIK 0001421914 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 149,145

F1 · kind: The sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by the reporting person on December 20, 2019.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.79 to $53.31, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Read SEC document
February 07, 2020 Filed Feb 11, 2020 18:00 UTC ARVINAS, INC. ARVN · Entity 5355 SaleCommon Stock 1,880 $52.30 $98,324.00
Disclosure

SEC source: 0001209191-20-008425 · doc4.xml · nonDerivative · entry 3

Cassidy Sean A · CIK 0001421914 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,447

F1 · kind: The sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by the reporting person on December 20, 2019.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.73 to $52.72, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Read SEC document
February 07, 2020 Filed Feb 11, 2020 18:00 UTC ARVINAS, INC. ARVN · Entity 5355 SaleCommon Stock 2,190 $50.97 $111,624.30
Disclosure

SEC source: 0001209191-20-008425 · doc4.xml · nonDerivative · entry 2

Cassidy Sean A · CIK 0001421914 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,327

F1 · kind: The sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by the reporting person on December 20, 2019.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.48 to $51.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range

Read SEC document
February 07, 2020 Filed Feb 11, 2020 18:00 UTC ARVINAS, INC. ARVN · Entity 5355 SaleCommon Stock 4,598 $49.97 $229,762.06
Disclosure

SEC source: 0001209191-20-008425 · doc4.xml · nonDerivative · entry 1

Cassidy Sean A · CIK 0001421914 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,517

F1 · kind: The sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by the reporting person on December 20, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.41 to $50.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Read SEC document
November 19, 2019 Filed Nov 21, 2019 17:45 UTC ARVINAS, INC. ARVN · Entity 5355 SaleCommon Stock 10,000 $32.00 $320,000.00
Disclosure

SEC source: 0001209191-19-057640 · doc4.xml · nonDerivative · entry 1

Cassidy Sean A · CIK 0001421914 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 159,115

F1 · kind: The sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by the reporting person on June 27, 2019.

Read SEC document
August 07, 2019 Filed Aug 9, 2019 16:04 UTC ARVINAS, INC. ARVN · Entity 5355 Exercise / conversionStock Option (right to buy) · Derivative 2,058 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001209191-19-045324 · doc4.xml · derivative · entry 4

Cassidy Sean A · CIK 0001421914 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,142

Underlying: Common Stock · 2,058 shares

Expires 2028-09-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of January 1, 2019, with the remainder of the shares vesting in equal monthly installments following January 1, 2019 through January 1, 2022.

Read SEC document
August 07, 2019 Filed Aug 9, 2019 16:04 UTC ARVINAS, INC. ARVN · Entity 5355 Exercise / conversionStock Option (right to buy) · Derivative 2,212 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001209191-19-045324 · doc4.xml · derivative · entry 3

Cassidy Sean A · CIK 0001421914 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,948

Underlying: Common Stock · 2,212 shares

Expires 2028-09-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of January 1, 2017, with the remainder of the shares vesting in equal monthly installments following January 1, 2017 through January 1, 2020.

Read SEC document
August 07, 2019 Filed Aug 9, 2019 16:04 UTC ARVINAS, INC. ARVN · Entity 5355 Exercise / conversionStock Option (right to buy) · Derivative 1,980 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001209191-19-045324 · doc4.xml · derivative · entry 2

Cassidy Sean A · CIK 0001421914 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,980 shares

Expires 2028-09-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: This option award was granted on September 26, 2018, and the shares underlying the award were fully vested upon grant.

Read SEC document
August 07, 2019 Filed Aug 9, 2019 16:04 UTC ARVINAS, INC. ARVN · Entity 5355 Exercise / conversionCommon Stock 6,250 $16.00 $100,000.00
Disclosure

SEC source: 0001209191-19-045324 · doc4.xml · nonDerivative · entry 1

Cassidy Sean A · CIK 0001421914 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 169,115

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 29, 2019 Filed Jul 31, 2019 17:43 UTC ARVINAS, INC. ARVN · Entity 5355 SaleCommon Stock 60 $28.03 $1,681.80
Disclosure

SEC source: 0000899243-19-020690 · doc4.xml · nonDerivative · entry 3

Cassidy Sean A · CIK 0001421914 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 162,865

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 27, 2019.

Read SEC document
July 29, 2019 Filed Jul 31, 2019 17:43 UTC ARVINAS, INC. ARVN · Entity 5355 SaleCommon Stock 1,108 $27.04 $29,960.32
Disclosure

SEC source: 0000899243-19-020690 · doc4.xml · nonDerivative · entry 2

Cassidy Sean A · CIK 0001421914 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 162,925

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 27, 2019.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.88 to $27.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Read SEC document
July 29, 2019 Filed Jul 31, 2019 17:43 UTC ARVINAS, INC. ARVN · Entity 5355 SaleCommon Stock 10,777 $26.13 $281,603.01
Disclosure

SEC source: 0000899243-19-020690 · doc4.xml · nonDerivative · entry 1

Cassidy Sean A · CIK 0001421914 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 164,033

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 27, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.75 to $26.72, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Read SEC document
March 01, 2019 Filed Mar 5, 2019 18:24 UTC ARVINAS, INC. ARVN · Entity 5355 GrantStock Option (right to buy) · Derivative 87,752 $0.00 Strike: $19.36 $0.00
Disclosure

SEC source: 0000899243-19-006227 · doc4.xml · derivative · entry 2

Cassidy Sean A · CIK 0001421914 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,752

Underlying: Common Stock · 87,752 shares

Expires 2029-02-28

F3 · derivative.exercise_date: This option award was granted on March 1, 2019. 1/4 of the shares underlying the award shall vest on March 1, 2020, with the remainder of the shares vesting in equal monthly installments following March 1, 2020 through March 1, 2023.

Read SEC document
March 01, 2019 Filed Mar 5, 2019 18:24 UTC ARVINAS, INC. ARVN · Entity 5355 GrantRestricted Stock Units · Derivative 19,165 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-006227 · doc4.xml · derivative · entry 1

Cassidy Sean A · CIK 0001421914 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,165

Underlying: Common Stock · 19,165 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning March 1, 2020.

F2 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning March 1, 2020.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 17:21 UTC ARVINAS, INC. ARVN · Entity 5355 ConversionSeries C Preferred Stock · Derivative 2,368 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-026071 · doc4.xml · derivative · entry 4

Cassidy Sean A · CIK 0001421914 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 728 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: On October 1, 2018, the Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a 3.25-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.

F2 · derivative.exercise_date: On October 1, 2018, the Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a 3.25-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.

F2 · derivative.expiration_date: On October 1, 2018, the Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a 3.25-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 17:21 UTC ARVINAS, INC. ARVN · Entity 5355 ConversionSeries B Preferred Stock · Derivative 15,007 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-026071 · doc4.xml · derivative · entry 3

Cassidy Sean A · CIK 0001421914 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,617 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: On October 1, 2018, the Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a 3.25-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.

F2 · derivative.exercise_date: On October 1, 2018, the Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a 3.25-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.

F2 · derivative.expiration_date: On October 1, 2018, the Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a 3.25-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 17:21 UTC ARVINAS, INC. ARVN · Entity 5355 ConversionCommon Stock 5,345 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-18-026071 · doc4.xml · nonDerivative · entry 2

Cassidy Sean A · CIK 0001421914 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 174,810

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: On October 1, 2018, the Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a 3.25-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 17:21 UTC ARVINAS, INC. ARVN · Entity 5355 PurchaseCommon Stock 1,600 $16.00 $25,600.00
Disclosure

SEC source: 0000899243-18-026071 · doc4.xml · nonDerivative · entry 1

Cassidy Sean A · CIK 0001421914 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 169,465

F1 · shares: Reflects shares of the Issuer's Common Stock that were purchased in connection with the Issuer's initial public offering.

Read SEC document
September 26, 2018 Filed Sep 28, 2018 20:43 UTC ARVINAS, INC. ARVN · Entity 5355 GrantStock Option (right to buy) · Derivative 27,330 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0000899243-18-025551 · doc4.xml · derivative · entry 6

Cassidy Sean A · CIK 0001421914 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,330

Underlying: Common Stock · 27,330 shares

Expires 2028-09-25

F6 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award shall vest on June 28, 2019, with the remainder of the shares vesting in equal monthly installments following June 28, 2019 through June 28, 2022.

Read SEC document
September 26, 2018 Filed Sep 28, 2018 20:43 UTC ARVINAS, INC. ARVN · Entity 5355 GrantStock Option (right to buy) · Derivative 81,770 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0000899243-18-025551 · doc4.xml · derivative · entry 5

Cassidy Sean A · CIK 0001421914 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,770

Underlying: Common Stock · 81,770 shares

Expires 2028-09-25

F5 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award shall vest on March 31, 2019, with the remainder of the shares vesting in equal monthly installments following March 31, 2019 through March 31, 2022.

Read SEC document
September 26, 2018 Filed Sep 28, 2018 20:43 UTC ARVINAS, INC. ARVN · Entity 5355 GrantStock Option (right to buy) · Derivative 5,200 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0000899243-18-025551 · doc4.xml · derivative · entry 4

Cassidy Sean A · CIK 0001421914 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,200

Underlying: Common Stock · 5,200 shares

Expires 2028-09-25

F4 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award shall vest on January 1, 2019, with the remainder of the shares vesting in equal monthly installments following January 1, 2019 through January 1, 2022.

Read SEC document
September 26, 2018 Filed Sep 28, 2018 20:43 UTC ARVINAS, INC. ARVN · Entity 5355 GrantStock Option (right to buy) · Derivative 15,160 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0000899243-18-025551 · doc4.xml · derivative · entry 3

Cassidy Sean A · CIK 0001421914 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,160

Underlying: Common Stock · 15,160 shares

Expires 2028-09-25

F3 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of January 1, 2017, with the remainder of the shares vesting in equal monthly installments following January 1, 2017 through January 1, 2020.

Read SEC document
September 26, 2018 Filed Sep 28, 2018 20:43 UTC ARVINAS, INC. ARVN · Entity 5355 GrantStock Option (right to buy) · Derivative 31,710 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0000899243-18-025551 · doc4.xml · derivative · entry 2

Cassidy Sean A · CIK 0001421914 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,710

Underlying: Common Stock · 31,710 shares

Expires 2028-09-25

F2 · derivative.exercise_date: This option award was granted on September 26, 2018, and the shares underlying the award were fully vested upon grant.

Read SEC document
September 26, 2018 Filed Sep 28, 2018 20:43 UTC ARVINAS, INC. ARVN · Entity 5355 GrantStock Option (right to buy) · Derivative 1,980 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0000899243-18-025551 · doc4.xml · derivative · entry 1

Cassidy Sean A · CIK 0001421914 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,980

Underlying: Common Stock · 1,980 shares

Expires 2028-09-25

F1 · derivative.exercise_date: This option award was granted on September 26, 2018, and the shares underlying the award were fully vested upon grant.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.